Skip to main content
. Author manuscript; available in PMC: 2008 Mar 17.
Published in final edited form as: Cell Immunol. 2007 Jan 25;243(1):19–29. doi: 10.1016/j.cellimm.2006.12.001

Table 2b.

CCR5 expression on CD14+ monocytes during migration across the IVBBB. This table demonstrates the CCR5 mean fluorescent intensity (MFI) values on CD14+ monocytes from 5 different donors. There was no change in MFI on migrated and non-migrated monocytes in either the basal IVBBB or aIVBBB models relative to the input. This table, coupled with the data in Figure 2a, indicates that CCR5 down-regulation on CD14+ monocytes following CCL5-driven migration is based on a reduced percentage of receptor-positive cells, rather than a reduced receptor surface expression per cell.

BBB MODEL CONDITION Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 p-value*
INPUT 22.7 22.6 37.9 28.8 46.1 n/a
Basal IVBBB No Chemokine-Non-migrated 23.0 21.4 32.9 28.7 44.0 n.s.
Basal IVBBB No Chemokine-Migrated 23.6 23.0 36.4 30.6 49.7 n.s.
Basal IVBBB + CCL5-Non-migrated 20.3 21.3 37.0 27.3 44.0 n.s.
Basal IVBBB + CCL5-Migrated 20.7 21.9 33.2 28.1 45.8 n.s.
aIVBBB No Chemokine-Non-migrated 23.5 21.6 36.9 27.9 44.3 n.s.
aIVBBB No Chemokine-Migrated 23.4 21.1 34.8 30.4 42.2 n.s.
aIVBBB + CCL5-Non-migrated 22.4 22.0 37.2 28.0 43.8 n.s.
aIVBBB + CCL5-Migrated 20.7 20.8 37.4 26.2 45.1 n.s.
*

indicates that p-values were ascertained relative to the input MFI. Key: aIVBBB: cytokine-activated in vitro blood-brain barrier, IVBBB: in vitro blood-brain barrier, n/a: not applicable, n.s.: not significant.